• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The Possible Interaction between Receptor Activator of Nuclear Factor Kappa-B Ligand Expressed by Extramammary Paget Cells and its Ligand on Dermal Macrophages.

作者信息

Kambayashi Yumi, Fujimura Taku, Furudate Sadanori, Asano Masayuki, Kakizaki Aya, Aiba Setsuya

机构信息

Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan..

出版信息

J Invest Dermatol. 2015 Oct;135(10):2547-2550. doi: 10.1038/jid.2015.199. Epub 2015 May 27.

DOI:10.1038/jid.2015.199
PMID:26016897
Abstract
摘要

相似文献

1
The Possible Interaction between Receptor Activator of Nuclear Factor Kappa-B Ligand Expressed by Extramammary Paget Cells and its Ligand on Dermal Macrophages.乳房外佩吉特细胞表达的核因子κB受体激活剂与其配体在真皮巨噬细胞上的可能相互作用。
J Invest Dermatol. 2015 Oct;135(10):2547-2550. doi: 10.1038/jid.2015.199. Epub 2015 May 27.
2
Receptor Activator of NF-κB Ligand Promotes the Production of CCL17 from RANK+ M2 Macrophages.核因子κB受体活化因子配体促进RANK⁺ M2巨噬细胞产生CCL17
J Invest Dermatol. 2015 Nov;135(11):2884-2887. doi: 10.1038/jid.2015.209. Epub 2015 Jun 8.
3
Possible mechanisms of the crosstalk between Langerhans cells and regulatory T cells in extramammary Paget disease by receptor activator of nuclear factor kappa B (RANK) ligand/RANK pathways.朗格汉斯细胞与调节性 T 细胞之间通过核因子 κB 受体激活剂（RANK）配体/RANK 通路相互作用在乳腺外派杰病中可能的机制。
Br J Dermatol. 2017 Feb;176(2):387-394. doi: 10.1111/bjd.14864. Epub 2016 Dec 22.
4
RANKL expression is a useful marker for differentiation of pagetoid squamous cell carcinoma in situ from extramammary Paget disease.RANKL表达是鉴别原位派杰样鳞状细胞癌与乳腺外佩吉特病的有用标志物。
J Cutan Pathol. 2016 Sep;43(9):772-5. doi: 10.1111/cup.12743. Epub 2016 Jun 20.
5
Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.核因子κB受体激活剂配体诱导破骨细胞前体RAW264.7细胞中碳酸酐酶II、组织蛋白酶K和基质金属蛋白酶-9的表达。
Life Sci. 2007 Mar 13;80(14):1311-8. doi: 10.1016/j.lfs.2006.12.037. Epub 2007 Jan 23.
6
Comparison of Foxp3+ regulatory T cells and CD163+ macrophages in invasive and non-invasive extramammary Paget's disease.比较侵袭性和非侵袭性乳腺外派杰氏病中 Foxp3+调节性 T 细胞和 CD163+巨噬细胞。
Acta Derm Venereol. 2012 Nov;92(6):625-8. doi: 10.2340/00015555-1453.
7
Expression of vascular endothelial growth factor and basic fibroblast growth factor in extramammary Paget disease.血管内皮生长因子和碱性成纤维细胞生长因子在乳房外佩吉特病中的表达
Int J Clin Exp Pathol. 2015 Mar 1;8(3):3062-8. eCollection 2015.
8
The Expression of Matrix Metalloproteinases in Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)-expressing Cancer of Apocrine Origin.基质金属蛋白酶在表达核因子κB受体活化因子配体（RANKL）的顶泌汗腺源性癌症中的表达
Anticancer Res. 2018 Jan;38(1):113-120. doi: 10.21873/anticanres.12198.
9
Oxidized low density lipoprotein enhanced RANKL expression in human osteoblast-like cells. Involvement of ERK, NFkappaB and NFAT.氧化型低密度脂蛋白增强人成骨样细胞中RANKL的表达。ERK、NFκB和NFAT的参与。
Biochim Biophys Acta. 2013 Oct;1832(10):1756-64. doi: 10.1016/j.bbadis.2013.05.033. Epub 2013 Jun 10.
10
Extramammary Paget Disease-A Challenging Case.乳腺外佩吉特病——一个具有挑战性的病例。
Am J Dermatopathol. 2019 Nov;41(11):867-868. doi: 10.1097/DAD.0000000000001311.

引用本文的文献

1
RANK/RANKL Signaling Pathway in Breast Development and Cancer.乳腺发育与癌症中的RANK/RANKL信号通路
Adv Exp Med Biol. 2025;1464:309-345. doi: 10.1007/978-3-031-70875-6_16.
2
An update to experimental and clinical aspects of tumor-associated macrophages in cancer development: hopes and pitfalls.肿瘤相关巨噬细胞在癌症发展中的实验和临床研究进展：希望与陷阱。
Clin Exp Med. 2024 Jul 13;24(1):156. doi: 10.1007/s10238-024-01417-w.
3
Targeting tumor-associated macrophages: Novel insights into immunotherapy of skin cancer.靶向肿瘤相关巨噬细胞：皮肤癌免疫治疗的新见解

本文引用的文献

1
Potential use of bisphosphonates in invasive extramammary Paget's disease: an immunohistochemical Investigation.双膦酸盐在侵袭性乳腺外佩吉特病中的潜在应用：一项免疫组织化学研究。
Clin Dev Immunol. 2013;2013:164982. doi: 10.1155/2013/164982. Epub 2013 Mar 31.
2
Comparison of Foxp3+ regulatory T cells and CD163+ macrophages in invasive and non-invasive extramammary Paget's disease.比较侵袭性和非侵袭性乳腺外派杰氏病中 Foxp3+调节性 T 细胞和 CD163+巨噬细胞。
Acta Derm Venereol. 2012 Nov;92(6):625-8. doi: 10.2340/00015555-1453.
3
The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients.
J Adv Res. 2025 Jan;67:231-252. doi: 10.1016/j.jare.2024.01.013. Epub 2024 Jan 17.
4
The Immunological Landscape of M1 and M2 Macrophages and Their Spatial Distribution in Patients with Malignant Pleural Mesothelioma.恶性胸膜间皮瘤患者中M1和M2巨噬细胞的免疫格局及其空间分布
Cancers (Basel). 2023 Oct 24;15(21):5116. doi: 10.3390/cancers15215116.
5
Stromal Factors as a Target for Immunotherapy in Melanoma and Non-Melanoma Skin Cancers.基质因子作为黑色素瘤和非黑色素瘤皮肤癌免疫治疗的靶点
Int J Mol Sci. 2022 Apr 6;23(7):4044. doi: 10.3390/ijms23074044.
6
RANKL biology.RANKL 生物学。
Bone. 2022 Jun;159:116353. doi: 10.1016/j.bone.2022.116353. Epub 2022 Feb 16.
7
Extramammary Paget's Disease: Diagnosis, Pathogenesis, and Treatment with Focus on Recent Developments.乳房外 Paget 病：诊断、发病机制和治疗，重点关注最新进展。
Curr Oncol. 2021 Aug 5;28(4):2969-2986. doi: 10.3390/curroncol28040260.
8
Significance of Immunosuppressive Cells as a Target for Immunotherapies in Melanoma and Non-Melanoma Skin Cancers.免疫抑制细胞作为黑色素瘤和非黑色素瘤皮肤癌免疫治疗靶点的意义。
Biomolecules. 2020 Jul 22;10(8):1087. doi: 10.3390/biom10081087.
9
Successful Treatment of Multiple Metastatic Melanoma with Nivolumab, Ipilimumab plus Denosumab Combined Therapy.纳武单抗、伊匹单抗联合地诺单抗治疗多发性转移性黑色素瘤取得成功
Case Rep Oncol. 2019 Oct 30;12(3):829-833. doi: 10.1159/000504019. eCollection 2019 Sep-Dec.
10
Dual targeting of RANKL and PD-1 with a bispecific antibody improves anti-tumor immunity.使用双特异性抗体对RANKL和PD-1进行双重靶向可增强抗肿瘤免疫力。
Clin Transl Immunology. 2019 Sep 27;8(10):e01081. doi: 10.1002/cti2.1081. eCollection 2019.
肿瘤相关巨噬细胞存在于肿瘤基质中作为乳腺癌患者的预后标志物。
BMC Cancer. 2012 Jul 23;12:306. doi: 10.1186/1471-2407-12-306.
4
Macrophages in tumor microenvironments and the progression of tumors.肿瘤微环境中的巨噬细胞与肿瘤进展
Clin Dev Immunol. 2012;2012:948098. doi: 10.1155/2012/948098. Epub 2012 Jun 19.
5
Clinicopathological study of invasive extramammary Paget's disease: subgroup comparison according to invasion depth.侵袭性乳腺外派杰氏病的临床病理研究：根据浸润深度的亚组比较。
J Eur Acad Dermatol Venereol. 2013 May;27(5):589-92. doi: 10.1111/j.1468-3083.2012.04489.x. Epub 2012 Feb 25.
6
RANKL inhibition: a promising novel strategy for breast cancer treatment.RANKL 抑制：乳腺癌治疗的一种有前途的新策略。
Clin Transl Oncol. 2011 Apr;13(4):222-8. doi: 10.1007/s12094-011-0646-5.
7
FOXP3+ regulatory T-cells are abundant in vulvar Paget's disease and are associated with recurrence.FOXP3+ 调节性 T 细胞在阴部 Paget 病中丰富，并与复发相关。
Gynecol Oncol. 2011 Feb;120(2):296-9. doi: 10.1016/j.ygyno.2010.10.019.
8
Contrary view: the breast is not an organ per se, but a distinctive region of skin and subcutaneous tissue.相反观点：乳房本身并非一个器官，而是皮肤和皮下组织的一个独特区域。
Am J Dermatopathol. 2007 Apr;29(2):211-8. doi: 10.1097/DAD.0b013e3180325d6b.
9
Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells.表皮RANKL通过激活树突状细胞来控制调节性T细胞的数量。
Nat Med. 2006 Dec;12(12):1372-9. doi: 10.1038/nm1518. Epub 2006 Dec 3.
10
Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse.调节性T细胞的定量分析有助于识别高危乳腺癌患者以及有晚期复发风险的患者。
J Clin Oncol. 2006 Dec 1;24(34):5373-80. doi: 10.1200/JCO.2006.05.9584.